GRACE :: Head/Neck Cancer

Jared Weiss

Denise Brock

Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers

Share

Dr. Jared Weiss, University of North Carolina School of Medicine

Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.

Joshua Bauml, MD, University of Pennsylvania

  

 


 Please feel free to offer comments and raise questions in our Discussion Forums.


 

 


Dr West

Dr. Weiss on Caveats and Emerging Concepts on HPV in Head/Neck Cancer

Share

The second of two parts of the webinar by Dr. Jared Weiss on HPV in head/neck cancer focuses on some caveats about the early conclusions we’ve reached about HPV, then follows with a discussion of several new research questions being addressed by emerging  clinical trials in this population.

Here are the video and audio versions of this podcast, along with the associated transcript and figures:

Weiss HPV Pt 2 SCCHN Caveats and New Concepts Audio Podcast

Weiss HPV Pt 2 SCCHN Caveats and New Concepts Transcript

Weiss HPV Pt 2 SCCHN Caveats and New Concepts Figures

Continue reading


Dr West

Dr. Weiss on the Importance of HPV in Head and Neck Cancer, Part 1

Share

What is HPVDr. Jared Weiss, specialist in head/neck and lung cancer at the University of North Carolina-Chapel Hill, contributed another excellent presentation recently on a topic in head and neck cancer that is dramatically changing the field as oncologists learn more about it. The human papilloma virus, or HPV, has long been known to be a critical factor in cervical cancer and some other cancer settings, but it has only been in recent years that we have begun to truly appreciate the magnitude of its impact in head and neck cancer and its potential relevance in practical management of head/neck cancer.  

Here is the first part of Dr. Weiss’s two-part program on HPV, focusing initially on defining HPV and its potential significance.

Weiss HPV Pt 1 Audio Podcast

Weiss HPV Pt 1 Transcript

Weiss HPV Pt 1 Figures

Continue reading


Dr West

Dr. Jared Weiss on Induction Therapy for Head and Neck Cancer, Part 1: Defining the Challenges

Share

What is induction therapyOur own Dr. Weiss was kind enough to do a couple of critically important programs on head and neck cancer for GRACE, which will significantly upgrade our offerings to this underserved and understudied patient population.  The first program he did was on induction, also known as neo-adjuvant or pre-operative, therapy for patients with head and neck cancer.  The first part of his presentation defined the problem, the potential value of induction therapy, and the challenges associated with delivering both effective and safe induction therapy.

Here are the video and audio versions of the podcast from part 1 of his program, along with the associated transcript and figures.

Weiss Induction Therapy for HNSCC Pt 1 Audio Podcast

Weiss Induction Therapy for HNSCC Pt 1 Transcript

Weiss Induction Therapy for HNSCC Pt 1 Figs

We’ll have the second half available here in just a few days.  Thanks so much to Dr. Weiss for doing this!


Ask Us, Q&A
Head/Neck Cancer Expert Content

Archives

Share

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243